Franklin Innovation Joins Nu-Med Plus Development Team For FDA Submission Of Nitric Oxide Hospital Medical Device
Published: Oct 10, 2017
SALT LAKE CITY, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical field, has selected Franklin Innovation to complement their existing NU-MED team and development partners. This addition will enhance NU-MED’s ability to aggressively move forward with pursuing FDA submission of their Nitric Oxide Hospital unit.
Franklin Innovation is a successful results oriented development firm with proven performance in electronic design and system integration along with the experience and the technical resources for developing successful products.
Inhaled Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns) and may have future applications for a variety of other diseases and complications that are currently being investigated. Commented Mr. Jeff Robins, President and CEO of Nu-Med-Plus. “We are excited to have Franklin Innovation join our existing team. Their expertise will help drive forward our project strategy to successfully submit and gain FDA approval for our Nitric Oxide hospital unit.”
About Nu-Med Plus, Inc.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of inhaled nitric oxide gas for therapeutic use. For more information please visit www.nu-medplus.com.
Jeff Robins/President 801-746-3570
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.